Indefinite Delivery Contract SPE2DB20D9226

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, awarded under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The task orders issued under this IDC cover a diverse array of pharmaceutical items such as Nexplanon implants, Mirena intrauterine systems, Botox, Xolair, Xtandi, and other specialized medications. The delivery orders have ceiling values ranging from hundreds to millions of dollars and are not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple medical product categories. This IDC positions DMS Pharmaceutical Group as a key supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.